ERS Genomics Enters into a Licensing Agreement with G+FLAS

shot by IP News Shots / 6:57 pm on 24 February, 2021

ERS Genomics Limited has announced the signing of a non-exclusive licensing agreement with G+FLAS Life Sciences for the former’s CRISPR-Cas9 patent portfolio. The financial terms of the agreement have not been divulged.

Read More at: https://www.genomeweb.com/business-news/ers-genomics-licenses-crispr-patents-korean-biotech-firm-gflas-life-sciences#.YDXoFugzY2x

Industry: Biotechnology | Type of IP: Deals - Licensing